Wesbanco Bank Inc Eli Lilly & CO Transaction History

Wesbanco Bank Inc

$2.89 Billion
Q3 2024

A detailed history of Wesbanco Bank Inc transactions in Eli Lilly & CO stock. As of the latest transaction made, Wesbanco Bank Inc holds 25,798 shares of LLY stock, worth $19.3 Million. This represents 0.79% of its overall portfolio holdings.

Number of Shares

25,798

Previous 27,406 5.87%

Holding current value

$19.3 Million

Previous $24.8 Million 7.89%

% of portfolio

0.79%

Previous 0.94%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 11, 2024	SELL	$772.14 - $960.02 $1.24 Million - $1.54 Million	-1,608 Reduced 5.87%	25,798 $22.9 Million
Q2 2024 Jul 11, 2024	SELL	$724.87 - $909.04 $865,494 - $1.09 Million	-1,194 Reduced 4.17%	27,406 $24.8 Million
Q1 2024 Apr 23, 2024	BUY	$592.2 - $792.28 $3.9 Million - $5.22 Million	6,586 Added 29.92%	28,600 $22.2 Million
Q4 2023 Feb 16, 2024	SELL	$525.19 - $619.13 $4.62 Million - $5.44 Million	-8,789 Reduced 28.53%	22,014 $12.8 Million
Q3 2023 Dec 11, 2023	SELL	$434.7 - $599.3 $88,678 - $122,257	-204 Reduced 0.66%	30,803 $16.5 Million
Q2 2023 Jul 13, 2023	SELL	$350.74 - $468.98 $882,812 - $1.18 Million	-2,517 Reduced 7.51%	31,007 $14.5 Million
Q1 2023 Apr 21, 2023	SELL	$310.63 - $364.82 $327,714 - $384,885	-1,055 Reduced 3.05%	33,524 $11.5 Million
Q4 2022 Jan 18, 2023	BUY	$321.55 - $374.67 $3.63 Million - $4.23 Million	11,297 Added 48.52%	34,579 $12.7 Million
Q3 2022 Oct 13, 2022	SELL	$296.48 - $337.87 $3.91 Million - $4.45 Million	-13,182 Reduced 36.15%	23,282 $7.53 Million
Q2 2022 Jul 18, 2022	SELL	$278.73 - $327.27 $13,936 - $16,363	-50 Reduced 0.14%	36,464 $11.8 Million
Q1 2022 Apr 25, 2022	SELL	$234.69 - $291.66 $27,458 - $34,124	-117 Reduced 0.32%	36,514 $10.5 Million
Q4 2021 Feb 02, 2022	SELL	$224.85 - $279.04 $245,985 - $305,269	-1,094 Reduced 2.9%	36,631 $10.1 Million
Q3 2021 Oct 12, 2021	SELL	$221.6 - $272.71 $520,316 - $640,323	-2,348 Reduced 5.86%	37,725 $8.72 Million
Q2 2021 Aug 09, 2021	SELL	$180.55 - $233.54 $202,757 - $262,265	-1,123 Reduced 2.73%	40,073 $9.2 Million
Q1 2021 May 06, 2021	SELL	$164.32 - $212.72 $40,258 - $52,116	-245 Reduced 0.59%	41,196 $7.7 Million
Q3 2020 Nov 13, 2020	BUY	$146.22 - $169.13 $368,035 - $425,700	2,517 Added 6.47%	41,441 $6.13 Million
Q2 2020 Jul 14, 2020	SELL	$136.42 - $164.18 $332,864 - $400,599	-2,440 Reduced 5.9%	38,924 $6.39 Million
Q1 2020 May 12, 2020	BUY	$119.05 - $147.35 $1.57 Million - $1.94 Million	13,192 Added 46.83%	41,364 $5.74 Million
Q4 2019 Feb 13, 2020	SELL	$106.92 - $132.43 $28,333 - $35,093	-265 Reduced 0.93%	28,172 $3.7 Million
Q3 2019 Nov 07, 2019	SELL	$106.79 - $116.16 $71,549 - $77,827	-670 Reduced 2.3%	28,437 $3.18 Million
Q2 2019 Aug 13, 2019	SELL	$110.79 - $129.32 $20,496 - $23,924	-185 Reduced 0.63%	29,107 $3.22 Million
Q1 2019 May 09, 2019	BUY	$111.31 - $131.02 $306,102 - $360,305	2,750 Added 10.36%	29,292 $3.8 Million
Q4 2018 Feb 05, 2019	BUY	$105.9 - $118.64 $10,060 - $11,270	95 Added 0.36%	26,542 $3.07 Million
Q3 2018 Nov 09, 2018	SELL	$85.86 - $107.31 $130,077 - $162,574	-1,515 Reduced 5.42%	26,447 $2.84 Million
Q2 2018 Aug 08, 2018	SELL	$75.7 - $86.88 $88,871 - $101,997	-1,174 Reduced 4.03%	27,962 $2.39 Million
Q1 2018 May 18, 2018	SELL	$74.21 - $87.6 $103,448 - $122,114	-1,394 Reduced 4.57%	29,136 $2.25 Million
Q4 2017 Feb 01, 2018	SELL	$81.94 - $87.89 $44,903 - $48,163	-548 Reduced 1.76%	30,530 $2.58 Million
Q3 2017 Nov 02, 2017	BUY	$77.07 - $85.54 $12,099 - $13,429	157 Added 0.51%	31,078 $2.66 Million
Q2 2017 Aug 08, 2017	BUY	N/A	30,921	30,921 $2.55 Million

Others Institutions Holding LLY

# of Institutions

4,003

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $713B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wesbanco Bank Inc, based on Form 13F filings with the SEC.

News

Stay updated on Wesbanco Bank Inc with notifications on news.

Account

Wesbanco Bank Inc Eli Lilly & CO Transaction History